No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
ASX Small-Cap Stocks to Watch
Anatara Lifesciences Ltd Names New Company Secretary
Anatara Lifesciences Ltd: Annual Report to shareholders
Anatara Lifesciences Ltd: Appendix 4E & Financial Report 30 June 2024
Anatara Lifesciences on Track to Meet Target Recruits for Stage-Two Irritable Bowel Syndrome Clinical Trial
Anatara Lifesciences Embarks on Stage 2 of GaRP Trial for Treatment of Irritable Bowel Syndrome